Masimo EBITDA Margin 2010-2024 | MASI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Masimo (MASI) over the last 10 years. The current EBITDA margin for Masimo as of December 31, 2024 is .
| Masimo EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $2.10B | $-0.16B | -7.68% |
| 2024-09-30 | $2.04B | $0.23B | 11.45% |
| 2024-06-30 | $2.02B | $0.23B | 11.35% |
| 2024-03-31 | $1.98B | $0.23B | 11.69% |
| 2023-12-31 | $2.05B | $0.24B | 11.57% |
| 2023-09-30 | $2.12B | $0.32B | 15.26% |
| 2023-06-30 | $2.19B | $0.31B | 13.95% |
| 2023-03-31 | $2.30B | $0.34B | 14.94% |
| 2022-12-31 | $2.04B | $0.35B | 17.05% |
| 2022-09-30 | $1.75B | $0.28B | 16.09% |
| 2022-06-30 | $1.50B | $0.33B | 21.68% |
| 2022-03-31 | $1.24B | $0.31B | 24.68% |
| 2021-12-31 | $1.24B | $0.31B | 25.18% |
| 2021-09-30 | $1.21B | $0.30B | 24.71% |
| 2021-06-30 | $1.18B | $0.29B | 24.47% |
| 2021-03-31 | $1.17B | $0.28B | 24.13% |
| 2020-12-31 | $1.14B | $0.28B | 24.83% |
| 2020-09-30 | $1.10B | $0.28B | 25.34% |
| 2020-06-30 | $1.05B | $0.27B | 25.67% |
| 2020-03-31 | $0.98B | $0.26B | 26.41% |
| 2019-12-31 | $0.94B | $0.24B | 25.99% |
| 2019-09-30 | $0.91B | $0.24B | 25.82% |
| 2019-06-30 | $0.90B | $0.23B | 25.89% |
| 2019-03-31 | $0.88B | $0.23B | 26.31% |
| 2018-12-31 | $0.86B | $0.23B | 26.66% |
| 2018-09-30 | $0.84B | $0.22B | 26.07% |
| 2018-06-30 | $0.83B | $0.21B | 25.91% |
| 2018-03-31 | $0.81B | $0.21B | 25.56% |
| 2017-12-31 | $0.79B | $0.20B | 25.82% |
| 2017-09-30 | $0.78B | $0.48B | 61.81% |
| 2017-06-30 | $0.76B | $0.48B | 62.93% |
| 2017-03-31 | $0.74B | $0.47B | 63.46% |
| 2016-12-31 | $0.71B | $0.45B | 63.53% |
| 2016-09-30 | $0.68B | $0.16B | 24.15% |
| 2016-06-30 | $0.66B | $0.16B | 23.34% |
| 2016-03-31 | $0.65B | $0.15B | 22.57% |
| 2015-12-31 | $0.63B | $0.14B | 21.55% |
| 2015-09-30 | $0.63B | $0.13B | 20.93% |
| 2015-06-30 | $0.62B | $0.13B | 20.26% |
| 2015-03-31 | $0.60B | $0.11B | 18.94% |
| 2014-12-31 | $0.59B | $0.12B | 19.76% |
| 2014-09-30 | $0.57B | $0.10B | 16.93% |
| 2014-06-30 | $0.55B | $0.09B | 16.97% |
| 2014-03-31 | $0.55B | $0.10B | 18.00% |
| 2013-12-31 | $0.55B | $0.09B | 16.85% |
| 2013-09-30 | $0.54B | $0.10B | 18.84% |
| 2013-06-30 | $0.52B | $0.10B | 18.51% |
| 2013-03-31 | $0.51B | $0.10B | 18.82% |
| 2012-12-31 | $0.49B | $0.09B | 19.07% |
| 2012-09-30 | $0.47B | $0.09B | 19.24% |
| 2012-06-30 | $0.46B | $0.09B | 20.09% |
| 2012-03-31 | $0.45B | $0.09B | 20.45% |
| 2011-12-31 | $0.44B | $0.09B | 21.41% |
| 2011-09-30 | $0.43B | $0.10B | 21.94% |
| 2011-06-30 | $0.43B | $0.10B | 22.79% |
| 2011-03-31 | $0.42B | $0.10B | 23.10% |
| 2010-12-31 | $0.41B | $0.11B | 27.59% |
| 2010-09-30 | $0.39B | $0.11B | 28.50% |
| 2010-06-30 | $0.38B | $0.11B | 29.02% |
| 2010-03-31 | $0.36B | $0.11B | 30.03% |
| 2009-12-31 | $0.35B | $0.09B | 25.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.438B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.004B | 88.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.550B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.755B | 30.00 |
| Alcon (ALC) | Switzerland | $44.308B | 29.94 |
| IDEXX Laboratories (IDXX) | United States | $41.667B | 47.88 |
| DexCom (DXCM) | United States | $33.517B | 51.81 |
| STERIS (STE) | Ireland | $24.719B | 27.26 |
| IQVIA Holdings (IQV) | United States | $24.708B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.055B | 28.61 |
| Waters (WAT) | United States | $21.392B | 30.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.121B | 0.00 |
| Hologic (HOLX) | United States | $12.655B | 13.75 |
| Penumbra (PEN) | United States | $10.870B | 85.31 |
| Sysmex ADR (SSMXY) | Japan | $10.657B | 30.23 |
| Globus Medical (GMED) | United States | $8.424B | 19.76 |
| Teleflex (TFX) | United States | $5.713B | 9.43 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.112B | 89.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.213B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.421B | 14.42 |
| Veracyte (VCYT) | United States | $2.287B | 32.09 |
| Nihon Kohden (NHNKY) | Japan | $2.213B | 25.38 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.894B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.537B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 118.04 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.055B | 5.61 |
| SiBone (SIBN) | United States | $0.843B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.78 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 14.54 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.43 |
| Delcath Systems (DCTH) | United States | $0.596B | 0.00 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| NeuroPace (NPCE) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| AxoGen (AXGN) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.474B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 12.13 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.165B | 0.00 |
| 908 Devices (MASS) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.141B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 44.60 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |